Per operative Intravenous Use of Dexmedetomidine to Reduce Post-operative Analgesic Requirement in Laparoscopic Cholecystectomy Operation

Background: Adequate control of postoperative pain is significant in enhancing patient comfort and recovery. Although opioids are frequently utilized for analgesia, their administration is frequently accompanied by dependency risks and side effects. Dexmedetomidine, a potent alpha-2 adrenergic agonist, has been investigated as a promising alternative because it possesses analgesic and opioid-sparing capabilities. Objective: To evaluate the efficacy of dexmedetomidine in managing postoperative pain and opioid consumption in patients undergoing laparoscopic cholecystectomy.Methods: Sixty patients undergoing laparoscopic cholecystectomy were randomly allocated to two groups: Group A was given infusion of dexmedetomidine at a dose of 0.5 µg/kg/hr and Group B was given normal saline. Postoperative pain was assessed at every 2 hours for 24 hours on the Visual Analog Scale (VAS). Opioid consumption (pethidine) was also noted at the same intervals. Data analysis was conducted with the help of SPSS v25 and statistical significance was considered at p<0.05. Results: VAS scores were consistently and significantly lower in Group A across all postoperative time points compared to Group B (p<0.01). Furthermore, Group A demonstrated a substantially lower need for pethidine throughout the 24-hour period (e.g., 47.0±3.6 mg vs. 72.6±2.3 mg at 2 hours; 25.4±2.4 mg vs. 64.3±2.8 mg at 24 hours; p<0.01). Conclusion: Dexmedetomidine reduces postoperative pain considerably and reduces opioid requirement, acting as a useful adjunct to postoperative pain management in patients undergoing laparoscopic cholecystectomy. Its twofold benefit of enhanced analgesia and reduced opioid consumption makes it an attractive solution to the problem of postoperative pain management and opioid excess. JAFMC Bangladesh, Vol-22, No-1, June 2026: 59-63

Authors

Institutions

Publication Details

Journal
Journal of Armed Forces Medical College Bangladesh
Published
2026-11-12
DOI
https://doi.org/10.3329/jafmc.v22i1.89824
Primary Topic
Anesthesia and Pain Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Per operative Intravenous Use of Dexmedetomidine to Reduce Post-operative Analgesic Requirement in Laparoscopic Cholecystectomy Operation

Nadeem Parvez Ali, Md Nazmul Haque
Journal of Armed Forces Medical College Bangladesh
Anesthesia and Pain Management
article

Per operative Intravenous Use of Dexmedetomidine to Reduce Post-operative Analgesic Requirement in Laparoscopic Cholecystectomy Operation

Nadeem Parvez Ali, Md Nazmul Haque
article en

Abstract

Background: Adequate control of postoperative pain is significant in enhancing patient comfort and recovery. Although opioids are frequently utilized for analgesia, their administration is frequently accompanied by dependency risks and side effects. Dexmedetomidine, a potent alpha-2 adrenergic agonist, has been investigated as a promising alternative because it possesses analgesic and opioid-sparing capabilities. Objective: To evaluate the efficacy of dexmedetomidine in managing postoperative pain and opioid consumption in patients undergoing laparoscopic cholecystectomy.Methods: Sixty patients undergoing laparoscopic cholecystectomy were randomly allocated to two groups: Group A was given infusion of dexmedetomidine at a dose of 0.5 µg/kg/hr and Group B was given normal saline. Postoperative pain was assessed at every 2 hours for 24 hours on the Visual Analog Scale (VAS). Opioid consumption (pethidine) was also noted at the same intervals. Data analysis was conducted with the help of SPSS v25 and statistical significance was considered at p<0.05. Results: VAS scores were consistently and significantly lower in Group A across all postoperative time points compared to Group B (p<0.01). Furthermore, Group A demonstrated a substantially lower need for pethidine throughout the 24-hour period (e.g., 47.0±3.6 mg vs. 72.6±2.3 mg at 2 hours; 25.4±2.4 mg vs. 64.3±2.8 mg at 24 hours; p<0.01). Conclusion: Dexmedetomidine reduces postoperative pain considerably and reduces opioid requirement, acting as a useful adjunct to postoperative pain management in patients undergoing laparoscopic cholecystectomy. Its twofold benefit of enhanced analgesia and reduced opioid consumption makes it an attractive solution to the problem of postoperative pain management and opioid excess. JAFMC Bangladesh, Vol-22, No-1, June 2026: 59-63

Journal of Armed Forces Medical College BangladeshVol. 22(1)
Combined Military Hospital (PK), Combined Military Hospital Dhaka (BD)
Good health and well-being
Anesthesia and Pain Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon